Beyond the Off-Label: A Systematic Review of What We Know About Clozapine Use for Children

被引:2
|
作者
Pimenta de Figueiredo, Thales [1 ]
de Almeida, Igor Ribeiro [1 ]
de Freitas, Filipe Augusto Cursino [2 ]
Kubrusly, Caio Hage Chahine [1 ]
Alvim-Soares Jr, Antonio Marcos [1 ]
de Miranda, Debora Marques [1 ]
机构
[1] Univ Fed Minas Gerais, 190 Ave Prof Alfredo Balena, BR-30130100 Belo Horizonte, MG, Brazil
[2] Fundacao Hosp Estado Minas Gerais, Belo Horizonte, Brazil
关键词
clozapine; children; psychopharmacology; aggressive behavior; DOUBLE-BLIND; ADOLESCENTS; ANTIPSYCHOTICS; AGGRESSION; DISORDER; YOUTHS;
D O I
10.1089/cap.2024.0070
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction: It is essential not to delay behavior management and control for aggression, violence, and impulsive behavior in young people. Clozapine has been widely used in adolescents and adults to manage violence and aggression in Schizophrenia. However, there are limited data on the use of clozapine in children, and no systematic review has addressed its use in this population.Objective and Methods: To better understand the conditions under which clozapine is used as a therapeutic alternative for nonschizophrenic diagnoses and to assess the current evidence supporting its prescription to children, a systematic review was conducted. The review followed PRISMA guidelines and was registered in PROSPERO under the ID CRD42024537707.Results: The review identified that all the studies used clozapine to address externalizing behavior, particularly aggressive behavior, and found positive outcomes supporting its use for treating children with treatment-resistant aggression. The studies also found that clozapine was well-tolerated in all cases. However, the studies were limited and mainly consisted of open trials without a control group.Conclusion: Further high-quality research is needed to establish precise guidelines for using clozapine in children.
引用
收藏
页码:e419 / e426
页数:8
相关论文
共 50 条
  • [41] What we know about high-growth firms, and what we do not: A systematic review
    Hamilton, Robert T.
    Ng, Poh Yen
    INTERNATIONAL SMALL BUSINESS JOURNAL-RESEARCHING ENTREPRENEURSHIP, 2025,
  • [42] Off-label drug use in children over the past decade: a scoping review
    Tang, Yuyi
    Li, Weiguo
    Liao, Jing
    Wang, Xiaoqing
    Baskota, Muna
    Liu, Enmei
    CHINESE MEDICAL JOURNAL, 2023, 136 (05) : 626 - 628
  • [43] Off-Label Use of rFVIIa in Children With Excessive Bleeding: A Consecutive Study of 153 Off-Label Uses in 139 Children
    Young, Guy
    Wicklund, Brian
    Neff, Philip
    Johnson, Chelsea
    Nugent, Diane J.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (02) : 179 - 183
  • [44] Off-label drug use in children over the past decade: a scoping review
    Tang Yuyi
    Li Weiguo
    Liao Jing
    Wang Xiaoqing
    Baskota Muna
    Liu Enmei
    中华医学杂志英文版, 2023, 136 (05)
  • [45] To Acne and Beyond: A Review of Sarecycline's Off-Label Uses
    Vidal, Savanna I.
    Menta, Nikita
    Friedman, Adam
    JOURNAL OF DRUGS IN DERMATOLOGY, 2024, 23 (09) : 792 - 793
  • [46] Recommendations on off-label use of intravenous azithromycin in children
    Zhou, Pengxiang
    Wang, Xiaoling
    Zhang, Xianglin
    Xu, Baoping
    Tong, Xiaomei
    Zhou, Wei
    Shen, Kunling
    Zhai, Suodi
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (07)
  • [47] What we know and do not know about authenticity in dining experiences: A systematic literature review
    Le, Truc H.
    Arcodia, Charles
    Novais, Margarida Abreu
    Kralj, Anna
    TOURISM MANAGEMENT, 2019, 74 : 258 - 275
  • [48] Off-label and unlicensed drug use in children Comment
    Kimland, E.
    PAEDIATRICS AND INTERNATIONAL CHILD HEALTH, 2014, 34 (01) : 1 - 2
  • [49] Off-label use of dalbavancin in children: a case series
    Gamell, Anna
    Velasco-Arnaiz, Eneritz
    Lopez-Ramos, Maria Goretti
    Rios-Barnes, Maria
    Simo-Nebot, Silvia
    Fumado, Victoria
    Noguera-Julian, Antoni
    Fortuny, Claudia
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (08) : 2062 - 2067